Mn Services Vermogensbeheer B.V. Acquires 3,931 Shares of CME Group Inc. $CME

Key Points

• Mn Services Vermogensbeheer B.V. increased its stake in CME Group by 2.9%, acquiring 3,931 shares to hold 140,210 shares valued at approximately $38.29 million.
• CME Group beat quarterly expectations with EPS of $2.77 versus $2.75 and revenue of $1.65 billion (up 8.1% year-over-year), while analysts project about 10.49 EPS for the current fiscal year.
• Dividend raised: CME boosted its quarterly payout to $1.30 (annualized $5.20), a 1.7% yield, with a dividend payout ratio of 46.59%.

Mn Services Vermogensbeheer B.V. grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 2.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 140,210 shares of the financial services provider's stock after acquiring an additional 3,931 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in CME Group were worth $38,289,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. MBM Wealth Consultants LLC grew its holdings in CME Group by 2.7% during the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider's stock valued at $392,000 after purchasing an additional 37 shares during the period. West Family Investments Inc. raised its stake in shares of CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider's stock worth $827,000 after buying an additional 37 shares during the period. Rehmann Capital Advisory Group raised its stake in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider's stock worth $243,000 after buying an additional 37 shares during the period. Atlatl Advisers LLC lifted its position in shares of CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider's stock valued at $574,000 after buying an additional 38 shares in the last quarter. Finally, 1248 Management LLC lifted its position in shares of CME Group by 26.8% during the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider's stock valued at $49,000 after buying an additional 38 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Price Performance

Shares of CME Group stock opened at $297.58 on Tuesday. The firm has a market cap of $106.72 billion, a PE ratio of 26.66, a PEG ratio of 3.17 and a beta of 0.24. The stock has a 50 day moving average of $303.12 and a 200 day moving average of $282.12. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $248.53 and a 12 month high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same period in the prior year, the firm earned $2.52 EPS. The company's revenue for the quarter was up 8.1% on a year-over-year basis. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. This is a boost from CME Group's previous quarterly dividend of $1.25. The ex-dividend date was Tuesday, March 10th. CME Group's dividend payout ratio (DPR) is currently 46.59%.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $262.00 to $266.00 and gave the company an "underweight" rating in a report on Thursday, February 5th. UBS Group reissued a "neutral" rating and issued a $310.00 price objective on shares of CME Group in a research note on Friday, February 6th. TD Cowen raised their price objective on shares of CME Group from $305.00 to $328.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. Rothschild & Co Redburn lifted their target price on shares of CME Group from $333.00 to $347.00 and gave the company a "neutral" rating in a research note on Thursday, March 12th. Finally, Jefferies Financial Group upped their target price on shares of CME Group from $302.00 to $356.00 and gave the stock a "buy" rating in a report on Monday, March 2nd. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of "Hold" and an average target price of $304.06.

Insider Buying and Selling

In other news, Director Dennis Suskind sold 748 shares of the business's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director owned 2,699 shares of the company's stock, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 8,539 shares of company stock valued at $2,713,821 over the last quarter. Company insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.